BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, ...

BioAtla (BCAB) announced preclinical poster presentations at the upcoming 2025 American Association for Cancer Research to be held at the ...

MARIETTA, Ohio (WTAP) - Every Spring, Marietta College hosts its All Scholars Day for students to showcase their research ...

Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer research from ...

Iksuda Therapeutics (Iksuda), the developer of class leading, clinically validated antibody drug conjugates (ADCs) today announces that it will present three posters at the American Association for ...

Poster presentation to highlight new data on MammaPrint® and BluePrint® utility for informing axillary surgery decisions in ...

Eupraxia's CEO, Dr. James Helliwell, will be presenting on May 5th, 2025, at 3:30pm ET at the Bloom Burton & Co. Healthcare Investor Conference being held at the Metro Toronto Convention Centre, and ...

Verismo Therapeutics, a clinical-stage CAR T company pioneering the KIR-CAR platform, today announced a Trials in Progress ...

Highlights of BioNTech’s oncology programs to be presented at AACR 2025: ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase Ib/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 ...

Pfizer advances bold vision for future of cancer care at the ASCO 2025 annual meeting: New York Friday, April 25, 2025, 10:00 Hrs [IST] Pfizer Inc. will showcase data across its p ...